| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.27B | 40.45B | 42.84B | 44.56B | 46.43B | 40.76B |
| Gross Profit | 8.04B | 8.32B | 7.72B | 7.81B | 10.43B | 8.98B |
| EBITDA | 2.77B | 2.80B | 2.50B | 2.88B | 5.47B | 4.16B |
| Net Income | 2.11B | 1.52B | 2.13B | 1.69B | 3.06B | 2.57B |
Balance Sheet | ||||||
| Total Assets | 52.89B | 59.52B | 52.06B | 58.19B | 54.04B | 52.52B |
| Cash, Cash Equivalents and Short-Term Investments | 6.93B | 8.80B | 6.70B | 9.60B | 8.33B | 8.14B |
| Total Debt | 7.15B | 7.81B | 5.74B | 5.90B | 6.25B | 6.62B |
| Total Liabilities | 21.80B | 24.61B | 20.48B | 22.18B | 21.82B | 23.67B |
| Stockholders Equity | 30.59B | 34.41B | 31.11B | 35.60B | 31.86B | 28.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.81B | 1.84B | 2.42B | 1.02B | 335.00M |
| Operating Cash Flow | 0.00 | 3.40B | 2.73B | 2.87B | 2.07B | 1.22B |
| Investing Cash Flow | 0.00 | -1.94B | 590.00M | -683.00M | -1.07B | -849.00M |
| Financing Cash Flow | 0.00 | 648.00M | -6.05B | -1.05B | -896.00M | -729.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥434.26B | 12.05 | ― | 3.26% | -6.84% | 4.65% | |
74 Outperform | ¥16.45B | 9.20 | ― | 2.73% | 13.36% | 29.00% | |
73 Outperform | ¥33.69B | 12.34 | ― | 1.71% | -1.17% | 27.95% | |
68 Neutral | ¥22.71B | 15.36 | ― | 6.00% | -5.60% | -18.54% | |
67 Neutral | ¥30.47B | 8.82 | ― | 4.13% | -3.15% | 29.33% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ¥35.35B | 13.50 | ― | 5.02% | -12.42% | -56.79% |